GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » Total Liabilities

Microbot Medical (FRA:CY9D) Total Liabilities : €2.39 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Microbot Medical Total Liabilities?

Microbot Medical's Total Liabilities for the quarter that ended in Dec. 2024 was €2.39 Mil.

Microbot Medical's quarterly Total Liabilities declined from Jun. 2024 (€1.28 Mil) to Sep. 2024 (€1.26 Mil) but then increased from Sep. 2024 (€1.26 Mil) to Dec. 2024 (€2.39 Mil).

Microbot Medical's annual Total Liabilities increased from Dec. 2022 (€2.12 Mil) to Dec. 2023 (€3.51 Mil) but then declined from Dec. 2023 (€3.51 Mil) to Dec. 2024 (€2.39 Mil).


Microbot Medical Total Liabilities Historical Data

The historical data trend for Microbot Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical Total Liabilities Chart

Microbot Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.62 2.11 2.12 3.51 2.39

Microbot Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.51 1.10 1.28 1.26 2.39

Microbot Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Microbot Medical's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.349+(0.039+-2.9837243786801E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.39

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=5.76-3.371
=2.39

Microbot Medical's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.349+(0.039+-2.9837243786801E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.39

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=5.76-3.371
=2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbot Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Microbot Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical Business Description

Traded in Other Exchanges
Address
175 Derby Street, Bld 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Microbot Medical Headlines

No Headlines